ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.89
0.70%
US Tech 100
18,062.00
-0.10%
S&P 500
5,303.27
0.12%
US Dollar vs CAD
1.36165
-0.01%
Bitcoin
67,013.57
-0.10%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Oncotelic Therapeutics Inc (QB) (OTLC)

  7. Oncotelic Therapeutics Inc (QB) (OTLC) News

OTLC

Oncotelic Therapeutics (QB) (OTLC)

Oncotelic Therapeutics Inc (QB)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:OTLC
DateTimeSourceHeadlineSymbolCompany
02/02/20244:00PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:OTLCOncotelic Therapeutics Inc (QB)
10/30/20238:00AMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:OTLCOncotelic Therapeutics Inc (QB)
08/23/20239:30AMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:OTLCOncotelic Therapeutics Inc (QB)
08/18/20234:00PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:OTLCOncotelic Therapeutics Inc (QB)
07/13/20238:25AMEdgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:OTLCOncotelic Therapeutics Inc (QB)
07/13/20238:15AMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:OTLCOncotelic Therapeutics Inc (QB)
06/30/20238:26AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:OTLCOncotelic Therapeutics Inc (QB)
06/30/20238:25AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:OTLCOncotelic Therapeutics Inc (QB)
06/20/202311:01AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:OTLCOncotelic Therapeutics Inc (QB)
06/16/202311:01AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:OTLCOncotelic Therapeutics Inc (QB)
05/31/20238:39AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:OTLCOncotelic Therapeutics Inc (QB)
05/19/20233:45PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:OTLCOncotelic Therapeutics Inc (QB)
05/02/20234:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:OTLCOncotelic Therapeutics Inc (QB)
04/20/20235:04AMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:OTLCOncotelic Therapeutics Inc (QB)
04/14/20234:02PMEdgar (US Regulatory)Annual Report (10-k)USOTC:OTLCOncotelic Therapeutics Inc (QB)
04/03/20235:04AMEdgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:OTLCOncotelic Therapeutics Inc (QB)
03/02/20238:01AMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:OTLCOncotelic Therapeutics Inc (QB)
12/07/20227:01AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:OTLCOncotelic Therapeutics Inc (QB)
11/25/20228:01AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:OTLCOncotelic Therapeutics Inc (QB)
11/18/20224:02PMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:OTLCOncotelic Therapeutics Inc (QB)
11/14/20221:25PMEdgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:OTLCOncotelic Therapeutics Inc (QB)
09/28/20228:16AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:OTLCOncotelic Therapeutics Inc (QB)
08/29/20228:16AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:OTLCOncotelic Therapeutics Inc (QB)
08/22/20227:32AMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:OTLCOncotelic Therapeutics Inc (QB)
08/15/20221:34PMEdgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:OTLCOncotelic Therapeutics Inc (QB)
07/15/20226:04AMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:OTLCOncotelic Therapeutics Inc (QB)
06/22/20227:47AMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:OTLCOncotelic Therapeutics Inc (QB)
05/23/20225:22AMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:OTLCOncotelic Therapeutics Inc (QB)
05/11/20224:11PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:OTLCOncotelic Therapeutics Inc (QB)
04/15/20223:28PMEdgar (US Regulatory)Annual Report (10-k)USOTC:OTLCOncotelic Therapeutics Inc (QB)
 Showing the most relevant articles for your search:USOTC:OTLC

Your Recent History

KRKN
XRPETH
Ripple
COIN
BICOETH
Biconomy Token
USOTC
LRDG
Lord Global (CE)
LSE
WOOD
Ishr G Tim&for
ASX
HSOKOB
NASDAQ
CALT
Calliditas Therapeutics AB
NASDAQ
REGLX
Regnan Global Equity Imp...
ASX
QBESSL
TSX
ADCO
Adcore
FX
HUFBRL
HUF vs BRL
LSE
NAVF
Nippon Active Value
NYSE
NFC.WS
New Frontier
LSE
BHGE
MRTX
DNTBTC
district0x
COIN
XESGBP
BIT
UI303C
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved